Slightly More Than Half of Pregnant Women With Epilepsy See Neurologist in Year Predelivery
FRIDAY, Sept. 19, 2025 -- Just over half (55 percent) of pregnant women with epilepsy (WWE) saw a neurologist in the year prior to delivery, according to a study presented at the American Neurological Association Annual Meeting, held from Sept. 13 to 16 in Baltimore.
Chloe Hill, M.D., from the University of Michigan in Ann Arbor, and colleagues characterized neurologist care during pregnancy among 2,385 WWE with a delivery date within the study period.
Overall, 55 percent saw a neurologist in the year prior to delivery. The researchers found that 59 percent of WWE were receiving one antiseizure medication (ASM) in the year prior to delivery, and 17 and 5 percent were receiving two and three or more ASMs, respectively; 19 percent had no ASM claims. Overall, 62 percent of WWE were receiving a recommended ASM, including levetiracetam, lamotrigine, and oxcarbazepine; 3, 10, and 0.3 percent were taking less favorable ASMs of valproic acid, topiramate, and phenobarbital, respectively. The likelihood of receiving a recommended ASM was increased for WWE who saw a neurologist (74 versus 48 percent), and they were less likely to stop taking their ASM (8 versus 33 percent). Use of a less favorable ASM and polytherapy were more common among WWE seen by a neurologist.
“This study of recent national data shows how many women with epilepsy may not be accessing the specialist care they need during pregnancy,” Hill said in a statement. "Seeing a neurologist during pregnancy is one important means to promote clinical practice guideline-concordant care for pregnant women with epilepsy, which supports safer pregnancies and healthier outcomes for women with epilepsy and their babies."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Read this next
Aspirin Linked to Lower CRC Recurrence for Molecularly Defined Subgroup
FRIDAY, Sept. 19, 2025 -- Aspirin is associated with a lower incidence of colorectal cancer (CRC) recurrence among certain patients with rectal or colon cancer with somatic...
Cannabis Use Increases Diabetes Risk Nearly Fourfold
FRIDAY, Sept. 19, 2025 -- Cannabis use is associated with a nearly quadrupled risk for developing type 2 diabetes, according to a study presented at the annual meeting of the...
Neonatal Male Circumcision Rates Reduced From 2012 to 2022
FRIDAY, Sept. 19, 2025 -- U.S. neonatal male circumcision (NMC) rates declined nearly 5 percent in the 10 years following the American Academy of Pediatrics statement supporting...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.